Terms: = Bone cancer AND IDH2, P48735, 3418, ENSG00000182054, IDHM, mNADP-IDH, IDH, IDP, ICD-M AND Prognosis
39 results:
1. Blast phase myeloproliferative neoplasm: contemporary review and 2024 treatment algorithm.
Tefferi A; Alkhateeb H; Gangat N
Blood Cancer J; 2023 Jul; 13(1):108. PubMed ID: 37460550
[TBL] [Abstract] [Full Text] [Related]
2. Distinct idh1/2-associated Methylation Profile and Enrichment of
Dermawan JKT; Nafa K; Mohanty A; Xu Y; Rijo I; Casanova J; Villafania L; Benhamida J; Kelly CM; Tap WD; Boland PJ; Fabbri N; Healey JH; Ladanyi M; Lu C; Hameed M
Cancer Res Commun; 2023 Mar; 3(3):431-443. PubMed ID: 36926116
[TBL] [Abstract] [Full Text] [Related]
3. JAK2V617F variant allele frequency, non-driver mutations, single-nucleotide variants and polycythemia vera outcome.
Kanduła Z; Janowski M; Więckowska B; Paczkowska E; Lewandowski K
J Cancer Res Clin Oncol; 2023 Jul; 149(8):4789-4803. PubMed ID: 36242602
[TBL] [Abstract] [Full Text] [Related]
4. Natural Coevolution of Tumor and Immunoenvironment in Glioblastoma.
Wu L; Wu W; Zhang J; Zhao Z; Li L; Zhu M; Wu M; Wu F; Zhou F; Du Y; Chai RC; Zhang W; Qiu X; Liu Q; Wang Z; Li J; Li K; Chen A; Jiang Y; Xiao X; Zou H; Srivastava R; Zhang T; Cai Y; Liang Y; Huang B; Zhang R; Lin F; Hu L; Wang X; Qian X; Lv S; Hu B; Zheng S; Hu Z; Shen H; You Y; Verhaak RGW; Jiang T; Wang Q
Cancer Discov; 2022 Dec; 12(12):2820-2837. PubMed ID: 36122307
[TBL] [Abstract] [Full Text] [Related]
5. A genetic model for central chondrosarcoma evolution correlates with patient outcome.
Cross W; Lyskjær I; Lesluyes T; Hargreaves S; Strobl AC; Davies C; Waise S; Hames-Fathi S; Oukrif D; Ye H; Amary F; Tirabosco R; Gerrand C; Baker T; Barnes D; Steele C; Alexandrov L; Bond G; ; Cool P; Pillay N; Van Loo P; Flanagan AM
Genome Med; 2022 Aug; 14(1):99. PubMed ID: 36042521
[TBL] [Abstract] [Full Text] [Related]
6. Periosteal chondrosarcoma: A case series in a referral center with survivorship analysis.
Pacheco M; Barra L; Gambarotti M; Magagnoli G; Sbaraglia M; Asioli S; Cocchi S; Carretta E; Frisoni T; Benini S; Dei Tos AP; Righi A
Eur J Surg Oncol; 2022 Aug; 48(8):1730-1738. PubMed ID: 35690562
[TBL] [Abstract] [Full Text] [Related]
7. Mutational landscape of blast phase myeloproliferative neoplasms (MPN-BP) and antecedent MPN.
Pasca S; Chifotides HT; Verstovsek S; Bose P
Int Rev Cell Mol Biol; 2022; 366():83-124. PubMed ID: 35153007
[TBL] [Abstract] [Full Text] [Related]
8. Clinicopathologic Features and prognosis of Olfactory Neuroblastoma with Isocitrate Dehydrogenase 2 Mutations.
Wu L; An J; Liu H
World Neurosurg; 2022 Mar; 159():e23-e31. PubMed ID: 34856401
[TBL] [Abstract] [Full Text] [Related]
9. Driver Genetic Mutations in Spinal Cord Gliomas Direct the Degree of Functional Impairment in Tumor-Associated Spinal Cord Injury.
Nagashima Y; Nishimura Y; Ohka F; Eguchi K; Aoki K; Ito H; Nishii T; Oyama T; Hara M; Kitano Y; Masaki H; Wakabayashi T; Natsume A
Cells; 2021 Sep; 10(10):. PubMed ID: 34685506
[TBL] [Abstract] [Full Text] [Related]
10. Prognostic impact of idh mutations in chondrosarcoma.
Nakagawa M; Sekimizu M; Endo M; Kobayashi E; Iwata S; Fukushima S; Yoshida A; Kitabayashi I; Ichikawa H; Kawai A; Nakatani F
J Orthop Sci; 2022 Nov; 27(6):1315-1322. PubMed ID: 34531086
[TBL] [Abstract] [Full Text] [Related]
11. Circulating tumour DNA is a promising biomarker for risk stratification of central chondrosarcoma with idh1/2 and GNAS mutations.
Lyskjaer I; Davies C; Strobl AC; Hindley J; James S; Lalam RK; Cross W; Hide G; Rankin KS; Jeys L; Tirabosco R; Stevenson J; ; O'Donnell P; Cool P; Flanagan AM
Mol Oncol; 2021 Dec; 15(12):3679-3690. PubMed ID: 34528398
[TBL] [Abstract] [Full Text] [Related]
12. Elevated mature monocytes in bone marrow accompanied with a higher IPSS-R score predicts a poor prognosis in myelodysplastic syndromes.
Wu A; Gao P; Wu N; Shi C; Huang Z; Rong C; Sun Y; Sheng L; Ouyang G; Mu Q
BMC Cancer; 2021 May; 21(1):546. PubMed ID: 33985456
[TBL] [Abstract] [Full Text] [Related]
13. Novel Targeted Therapeutics in Acute Myeloid Leukemia: an Embarrassment of Riches.
Grieselhuber NR; Mims AS
Curr Hematol Malig Rep; 2021 Apr; 16(2):192-206. PubMed ID: 33738705
[TBL] [Abstract] [Full Text] [Related]
14. Gliosarcoma in patients under 20 years of age. A clinicopathologic study of 11 cases and detailed review of the literature.
Din NU; Ishtiaq H; Rahim S; Abdul-Ghafar J; Ahmad Z
BMC Pediatr; 2021 Feb; 21(1):101. PubMed ID: 33637068
[TBL] [Abstract] [Full Text] [Related]
15. Clinical significance of cytogenetic and molecular genetic abnormalities in 634 Chinese patients with myelodysplastic syndromes.
Yan X; Wang L; Jiang L; Luo Y; Lin P; Yang W; Ren Y; Ma L; Zhou X; Mei C; Ye L; Xu G; Xu W; Yang H; Lu C; Jin J; Tong H
Cancer Med; 2021 Mar; 10(5):1759-1771. PubMed ID: 33609081
[TBL] [Abstract] [Full Text] [Related]
16. TP-0903 is active in models of drug-resistant acute myeloid leukemia.
Jeon JY; Buelow DR; Garrison DA; Niu M; Eisenmann ED; Huang KM; Zavorka Thomas ME; Weber RH; Whatcott CJ; Warner SL; Orwick SJ; Carmichael B; Stahl E; Brinton LT; Lapalombella R; Blachly JS; Hertlein E; Byrd JC; Bhatnagar B; Baker SD
JCI Insight; 2020 Dec; 5(23):. PubMed ID: 33268594
[TBL] [Abstract] [Full Text] [Related]
17. Targeted Next-Generation Sequencing Identifies Molecular and Genetic Events in Dedifferentiated Chondrosarcoma.
Lucas CG; Grenert JP; Horvai A
Arch Pathol Lab Med; 2021 Aug; 145(8):1009-1017. PubMed ID: 33147331
[TBL] [Abstract] [Full Text] [Related]
18. Extracranial metastases in secondary glioblastoma multiforme: a case report.
Rossi J; Giaccherini L; Cavallieri F; Napoli M; Moratti C; Froio E; Serra S; Fraternali A; Ghadirpour R; Cozzi S; Ciammella P; Iaccarino C; Pascarella R; Valzania F; Pisanello A
BMC Neurol; 2020 Oct; 20(1):382. PubMed ID: 33087049
[TBL] [Abstract] [Full Text] [Related]
19. Decitabine in combination with low-dose cytarabine, aclarubicin and G-CSF tends to improve prognosis in elderly patients with high-risk AML.
Hong M; Zhu H; Sun Q; Zhu Y; Miao Y; Yang H; Qiu HR; Li JY; Qian SX
Aging (Albany NY); 2020 Apr; 12(7):5792-5811. PubMed ID: 32238611
[TBL] [Abstract] [Full Text] [Related]
20. [Primary skull base chondrosarcoma: a clinicopathological analysis].
Zhang Y; Chen XN; Ren CH; Jiang CZ; Chen YP; Lin N; Wang M; Cai SS; Li GP; Zhang S; Wang XF
Zhonghua Bing Li Xue Za Zhi; 2020 Mar; 49(3):239-243. PubMed ID: 32187895
[No Abstract] [Full Text] [Related]
[Next]